hwa 138 has been researched along with a 802715 in 2 studies
| Studies (hwa 138) | Trials (hwa 138) | Recent Studies (post-2010) (hwa 138) | Studies (a 802715) | Trials (a 802715) | Recent Studies (post-2010) (a 802715) |
|---|---|---|---|---|---|
| 22 | 0 | 0 | 9 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alléra, A; Eisenhut, T; Endres, S; Gebert, U; Moeller, J; Schönharting, MM; Semmler, J | 1 |
| Birg, A; Frank, G; Hoffmann, H; Jochum, M; Schönharting, MM; Weis, M | 1 |
2 other study(ies) available for hwa 138 and a 802715
| Article | Year |
|---|---|
Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Pentoxifylline; Theophylline; Tumor Necrosis Factor-alpha; Xanthines | 1993 |
Amelioration of endotoxin-induced acute lung injury in pigs by HWA 138 and A 80 2715: new analogs of pentoxifylline.
Topics: Animals; Bronchodilator Agents; Hemodynamics; Infusions, Intravenous; Leukocyte Count; Leukopenia; Lipopolysaccharides; Pentoxifylline; Pulmonary Circulation; Respiratory Distress Syndrome; Shock, Septic; Swine; Swine, Miniature; Xanthines | 1995 |